UBE1L antibody [N1N2], N-term

GeneTex

UBE1L antibody [N1N2], N-term

9

WB: 1:500-1:3000. IHC-P: 1:100-1:1000. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.

Western Blot, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin

Research Use Only

Polyclonal

1 mg/ml

Unconjugated

UBA7

ubiquitin like modifier activating enzyme 7

D8, UBA1B, UBE1L, UBE2, UBE7, ubiquitin-like modifier-activating enzyme 7, UBA1, ubiquitin-activating enzyme E1 homolog B, UBA7, ubiquitin-activating enzyme E1, ubiquitin-activating enzyme 7, ubiquitin-activating enzyme E1 homolog, ubiquitin-activating enzyme E1-related protein, ubiquitin-activating enzyme-2

Rabbit

IgG

Ubiquitin-like modifier-activating enzyme 7

The modification of proteins with ubiquitin is an important cellular mechanism for targeting abnormal or short-lived proteins for degradation. Ubiquitination involves at least three classes of enzymes: ubiquitin-activating enzymes, or E1s, ubiquitin-conjugating enzymes, or E2s, and ubiquitin-protein ligases, or E3s. This gene encodes a member of the E1 ubiquitin-activating enzyme family. The encoded enzyme is a retinoid target that triggers promyelocytic leukemia (PML)/retinoic acid receptor alpha (RARalpha) degradation and apoptosis in acute promyelocytic leukemia, where it is involved in the conjugation of the ubiquitin-like interferon-stimulated gene 15 protein. [provided by RefSeq]

Human

-20°C or -80°C,2°C to 8°C

41116161